Drugs / VEE VLP Vaccine
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT03776994 | Jul 2018 → Jul 2020 | Venezuelan equine encephalitis, viral encephalitis | SRI International | Unknown | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | VEE VLP Vaccine | “The monovalent VEE VLP vaccine (the same VEE VLP study agent which comprises the VEE portion of the NIAID trivalent alphaviral VLP vaccine)” NCT03776994 ↗ |
| Known as | monovalent VEE VLP vaccine | “The monovalent VEE VLP vaccine (the same VEE VLP study agent which comprises the VEE portion of the NIAID trivalent alphaviral VLP vaccine)” NCT03776994 ↗ |
| Modality | Vaccine | “VLP vaccine” NCT03776994 ↗ |
| Route | Intramuscular | “administered via intramuscular (IM) injection” NCT03776994 ↗ |